Cabaletta Bio (CABA) Total Current Liabilities (2018 - 2025)

Cabaletta Bio's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $50.2 million for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 85.16% year-over-year to $50.2 million; the TTM figure through Dec 2025 stood at $50.2 million (up 85.16% YoY), while the FY2025 annual figure was $50.2 million, up 85.16% from the prior year.
• Total Current Liabilities was $50.2 million for Q4 2025 at Cabaletta Bio, up from $45.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $50.2 million in Q4 2025 to a low of $4.0 million in Q1 2021.
• Historically, Total Current Liabilities has averaged $17.7 million across 5 years, with a median of $10.1 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities declined 3.69% in 2022, then surged 132.08% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $8.4 million in 2021, then grew by 13.23% to $9.5 million in 2022, then surged by 68.55% to $16.0 million in 2023, then surged by 69.35% to $27.1 million in 2024, then jumped by 85.16% to $50.2 million in 2025.
• The last three Total Current Liabilities figures came in at $50.2 million (Q4 2025), $45.7 million (Q3 2025), and $41.5 million (Q2 2025), per Business Quant data.